138 related articles for article (PubMed ID: 15809764)
1. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
3. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Wasmuth HE; Zaldivar MM; Berres ML; Werth A; Scholten D; Hillebrandt S; Tacke F; Schmitz P; Dahl E; Wiederholt T; Hellerbrand C; Berg T; Weiskirchen R; Trautwein C; Lammert F
J Hepatol; 2008 Feb; 48(2):208-15. PubMed ID: 18078680
[TBL] [Abstract][Full Text] [Related]
4. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N
J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338
[TBL] [Abstract][Full Text] [Related]
6. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
Liu Y; Poon RT; Feng X; Yu WC; Luk JM; Fan ST
Am J Gastroenterol; 2004 Jun; 99(6):1111-21. PubMed ID: 15180734
[TBL] [Abstract][Full Text] [Related]
9. Association study between the CX3CR1 gene and asthma.
Tremblay K; Lemire M; Provost V; Pastinen T; Renaud Y; Sandford AJ; Laviolette M; Hudson TJ; Laprise C
Genes Immun; 2006 Dec; 7(8):632-9. PubMed ID: 17082760
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.
Rodero M; Marie Y; Coudert M; Blondet E; Mokhtari K; Rousseau A; Raoul W; Carpentier C; Sennlaub F; Deterre P; Delattre JY; Debré P; Sanson M; Combadière C
J Clin Oncol; 2008 Dec; 26(36):5957-64. PubMed ID: 19001328
[TBL] [Abstract][Full Text] [Related]
11. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
12. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension.
Marasini B; Cossutta R; Selmi C; Pozzi MR; Gardinali M; Massarotti M; Erario M; Battaglioli L; Biondi ML
Clin Dev Immunol; 2005 Dec; 12(4):275-9. PubMed ID: 16584113
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma.
Hsu LM; Huang YS; Yang SY; Chang FY; Lee SD
Anticancer Res; 2006; 26(5B):3787-91. PubMed ID: 17094402
[TBL] [Abstract][Full Text] [Related]
15. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
16. [The genetic polymorphism of melanoma-associated antigen 1 in Chinese normal donors and hepatoma patients].
Wang LP; Chen HS; Mei MH; Qin LL; Cong X; Fei R; Xu J; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):151-5. PubMed ID: 15059299
[TBL] [Abstract][Full Text] [Related]
17. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
[TBL] [Abstract][Full Text] [Related]
18. The CX3CL1-CX3CR1 system and psoriasis.
Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]